Nov 05, 2024 / 10:00PM GMT
Operator
Good afternoon and welcome to the Ultragenyx third-quarter 2024 financial results conference call. (Operator Instructions) It is now my pleasure to turn the call to Joshua Higa, Vice President of Investor Relations. Thank you.
Joshua Higa - Ultragenyx Pharmaceutical Inc - Investor Relations
We've issued a press release detailing our financial results, which you can find on our website at Ultragenyx.com. Joining me on this call are Emil Kakkis, Chief Executive Officer and President, Erik Harris, Chief Commercial Officer, Howard Horn, Chief Financial Officer, and Eric Krondes, Chief Medical Officer. I'd like to remind everyone that during today's call, we will be making forward-looking statements. These statements are subject to certain risks and uncertainties, and our actual results may differ materially. Please refer to the risk factors discussed in our latest SEC files. I'll now turn the call over to Emil.
Emil Kakkis - Ultragenyx Pharmaceutical Inc - President, Chief Executive Officer, Director
Thanks, Josh, and good
Q3 2024 Ultragenyx Pharmaceutical Inc Earnings Call Transcript
Nov 06, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers